nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP2D6—Hydroxyurea—head and neck cancer	0.0864	0.238	CbGbCtD
Aripiprazole—CYP3A7—Docetaxel—head and neck cancer	0.0548	0.151	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0548	0.151	CbGbCtD
Aripiprazole—CYP3A5—Docetaxel—head and neck cancer	0.0411	0.113	CbGbCtD
Aripiprazole—ABCB1—Vinblastine—head and neck cancer	0.0325	0.0896	CbGbCtD
Aripiprazole—CYP2D6—Vinblastine—head and neck cancer	0.0306	0.0844	CbGbCtD
Aripiprazole—ABCB1—Docetaxel—head and neck cancer	0.0268	0.0738	CbGbCtD
Aripiprazole—DRD5—eyelid—head and neck cancer	0.021	0.123	CbGeAlD
Aripiprazole—CYP3A4—Vinblastine—head and neck cancer	0.0194	0.0537	CbGbCtD
Aripiprazole—CYP3A4—Docetaxel—head and neck cancer	0.016	0.0442	CbGbCtD
Aripiprazole—HTR7—superior cervical ganglion—head and neck cancer	0.013	0.0755	CbGeAlD
Aripiprazole—HTR1B—trigeminal nerve—head and neck cancer	0.0095	0.0553	CbGeAlD
Aripiprazole—HTR1D—trigeminal nerve—head and neck cancer	0.00919	0.0536	CbGeAlD
Aripiprazole—HTR3A—cranial nerve—head and neck cancer	0.00806	0.047	CbGeAlD
Aripiprazole—HRH1—nose—head and neck cancer	0.00697	0.0406	CbGeAlD
Aripiprazole—HTR1B—cranial nerve—head and neck cancer	0.00677	0.0394	CbGeAlD
Aripiprazole—HTR1D—cranial nerve—head and neck cancer	0.00655	0.0382	CbGeAlD
Aripiprazole—HTR7—cranial nerve—head and neck cancer	0.00522	0.0304	CbGeAlD
Aripiprazole—HTR2A—trigeminal nerve—head and neck cancer	0.00457	0.0266	CbGeAlD
Aripiprazole—H1F0—hair follicle—head and neck cancer	0.00363	0.0211	CbGeAlD
Aripiprazole—HTR2A—cranial nerve—head and neck cancer	0.00325	0.019	CbGeAlD
Aripiprazole—CHRM3—exocrine gland—head and neck cancer	0.00247	0.0144	CbGeAlD
Aripiprazole—H1F0—neck—head and neck cancer	0.00243	0.0142	CbGeAlD
Aripiprazole—H1F0—parotid gland—head and neck cancer	0.00198	0.0116	CbGeAlD
Aripiprazole—CHRM5—epithelium—head and neck cancer	0.00192	0.0112	CbGeAlD
Aripiprazole—H1F0—saliva-secreting gland—head and neck cancer	0.0019	0.0111	CbGeAlD
Aripiprazole—HTR7—mouth—head and neck cancer	0.00176	0.0102	CbGeAlD
Aripiprazole—H1F0—connective tissue—head and neck cancer	0.00174	0.0102	CbGeAlD
Aripiprazole—HTR1E—head—head and neck cancer	0.00174	0.0101	CbGeAlD
Aripiprazole—DRD5—lymphoid tissue—head and neck cancer	0.00165	0.00961	CbGeAlD
Aripiprazole—CHRM4—head—head and neck cancer	0.00153	0.00889	CbGeAlD
Aripiprazole—HTR7—neck—head and neck cancer	0.0015	0.00876	CbGeAlD
Aripiprazole—H1F0—trachea—head and neck cancer	0.00146	0.00854	CbGeAlD
Aripiprazole—CHRM1—parotid gland—head and neck cancer	0.00144	0.00837	CbGeAlD
Aripiprazole—DRD3—head—head and neck cancer	0.00142	0.00826	CbGeAlD
Aripiprazole—CHRM1—saliva-secreting gland—head and neck cancer	0.00138	0.00802	CbGeAlD
Aripiprazole—HTR6—head—head and neck cancer	0.00136	0.00795	CbGeAlD
Aripiprazole—HTR1D—connective tissue—head and neck cancer	0.00135	0.00788	CbGeAlD
Aripiprazole—DRD5—head—head and neck cancer	0.00133	0.00774	CbGeAlD
Aripiprazole—ADRB1—connective tissue—head and neck cancer	0.00131	0.00766	CbGeAlD
Aripiprazole—H1F0—lymphoid tissue—head and neck cancer	0.00128	0.00744	CbGeAlD
Aripiprazole—CHRM3—saliva-secreting gland—head and neck cancer	0.00123	0.00718	CbGeAlD
Aripiprazole—CHRM5—head—head and neck cancer	0.00119	0.00695	CbGeAlD
Aripiprazole—H1F0—thyroid gland—head and neck cancer	0.00116	0.00675	CbGeAlD
Aripiprazole—ADRA2C—parotid gland—head and neck cancer	0.00112	0.00655	CbGeAlD
Aripiprazole—ADRA1B—head—head and neck cancer	0.00109	0.00635	CbGeAlD
Aripiprazole—HTR7—connective tissue—head and neck cancer	0.00108	0.00628	CbGeAlD
Aripiprazole—CHRM1—trachea—head and neck cancer	0.00106	0.00619	CbGeAlD
Aripiprazole—H1F0—head—head and neck cancer	0.00103	0.00599	CbGeAlD
Aripiprazole—HTR7—epithelium—head and neck cancer	0.00102	0.00596	CbGeAlD
Aripiprazole—DRD1—head—head and neck cancer	0.00102	0.00592	CbGeAlD
Aripiprazole—ADRA1A—epithelium—head and neck cancer	0.000986	0.00575	CbGeAlD
Aripiprazole—HTR3A—head—head and neck cancer	0.000981	0.00571	CbGeAlD
Aripiprazole—HTR2A—neck—head and neck cancer	0.000937	0.00546	CbGeAlD
Aripiprazole—HTR7—trachea—head and neck cancer	0.000904	0.00527	CbGeAlD
Aripiprazole—Neuropathy—Docetaxel—head and neck cancer	0.000845	0.00253	CcSEcCtD
Aripiprazole—Alopecia—Vinblastine—head and neck cancer	0.000843	0.00252	CcSEcCtD
Aripiprazole—HTR2B—thyroid gland—head and neck cancer	0.000835	0.00487	CbGeAlD
Aripiprazole—ADRA2C—trachea—head and neck cancer	0.000831	0.00484	CbGeAlD
Aripiprazole—Dry skin—Fluorouracil—head and neck cancer	0.000829	0.00248	CcSEcCtD
Aripiprazole—HTR1B—head—head and neck cancer	0.000823	0.00479	CbGeAlD
Aripiprazole—Oesophagitis—Docetaxel—head and neck cancer	0.000822	0.00246	CcSEcCtD
Aripiprazole—CHRM2—head—head and neck cancer	0.000818	0.00477	CbGeAlD
Aripiprazole—Neoplasm—Docetaxel—head and neck cancer	0.000813	0.00243	CcSEcCtD
Aripiprazole—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000809	0.00242	CcSEcCtD
Aripiprazole—Lightheadedness—Docetaxel—head and neck cancer	0.000805	0.00241	CcSEcCtD
Aripiprazole—HRH1—connective tissue—head and neck cancer	0.000804	0.00469	CbGeAlD
Aripiprazole—Pulmonary oedema—Docetaxel—head and neck cancer	0.000801	0.0024	CcSEcCtD
Aripiprazole—Muscular weakness—Fluorouracil—head and neck cancer	0.000798	0.00239	CcSEcCtD
Aripiprazole—HTR1D—head—head and neck cancer	0.000796	0.00464	CbGeAlD
Aripiprazole—ADRA2A—connective tissue—head and neck cancer	0.00079	0.0046	CbGeAlD
Aripiprazole—Angiopathy—Hydroxyurea—head and neck cancer	0.000789	0.00236	CcSEcCtD
Aripiprazole—HTR2C—head—head and neck cancer	0.000789	0.0046	CbGeAlD
Aripiprazole—Dysphagia—Fluorouracil—head and neck cancer	0.000782	0.00234	CcSEcCtD
Aripiprazole—Chills—Hydroxyurea—head and neck cancer	0.00078	0.00234	CcSEcCtD
Aripiprazole—Eosinophilia—Fluorouracil—head and neck cancer	0.000774	0.00232	CcSEcCtD
Aripiprazole—ADRB1—head—head and neck cancer	0.000774	0.00451	CbGeAlD
Aripiprazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.00077	0.0023	CcSEcCtD
Aripiprazole—Alopecia—Hydroxyurea—head and neck cancer	0.000769	0.0023	CcSEcCtD
Aripiprazole—Anaemia—Vinblastine—head and neck cancer	0.000767	0.0023	CcSEcCtD
Aripiprazole—HRH1—epithelium—head and neck cancer	0.000763	0.00445	CbGeAlD
Aripiprazole—Angina pectoris—Fluorouracil—head and neck cancer	0.000762	0.00228	CcSEcCtD
Aripiprazole—ADRA1A—lymphoid tissue—head and neck cancer	0.000759	0.00443	CbGeAlD
Aripiprazole—Phlebitis—Docetaxel—head and neck cancer	0.000758	0.00227	CcSEcCtD
Aripiprazole—Erythema—Hydroxyurea—head and neck cancer	0.000757	0.00227	CcSEcCtD
Aripiprazole—Thrombophlebitis—Docetaxel—head and neck cancer	0.000754	0.00226	CcSEcCtD
Aripiprazole—CHRM3—thyroid gland—head and neck cancer	0.000751	0.00438	CbGeAlD
Aripiprazole—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000751	0.00225	CcSEcCtD
Aripiprazole—Malaise—Vinblastine—head and neck cancer	0.000749	0.00224	CcSEcCtD
Aripiprazole—SLC6A4—head—head and neck cancer	0.000748	0.00436	CbGeAlD
Aripiprazole—Vertigo—Vinblastine—head and neck cancer	0.000746	0.00223	CcSEcCtD
Aripiprazole—CHRM1—head—head and neck cancer	0.000745	0.00434	CbGeAlD
Aripiprazole—Leukopenia—Vinblastine—head and neck cancer	0.000743	0.00222	CcSEcCtD
Aripiprazole—HTR2B—head—head and neck cancer	0.000741	0.00432	CbGeAlD
Aripiprazole—Swelling—Docetaxel—head and neck cancer	0.00074	0.00222	CcSEcCtD
Aripiprazole—Deafness—Docetaxel—head and neck cancer	0.00073	0.00218	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000727	0.00218	CcSEcCtD
Aripiprazole—Hepatic failure—Docetaxel—head and neck cancer	0.000727	0.00217	CcSEcCtD
Aripiprazole—H1F0—lymph node—head and neck cancer	0.00072	0.0042	CbGeAlD
Aripiprazole—Convulsion—Vinblastine—head and neck cancer	0.000719	0.00215	CcSEcCtD
Aripiprazole—Hypertension—Vinblastine—head and neck cancer	0.000717	0.00214	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000714	0.00214	CcSEcCtD
Aripiprazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000702	0.0021	CcSEcCtD
Aripiprazole—Pneumonia—Fluorouracil—head and neck cancer	0.000701	0.0021	CcSEcCtD
Aripiprazole—Anaemia—Hydroxyurea—head and neck cancer	0.0007	0.00209	CcSEcCtD
Aripiprazole—Discomfort—Vinblastine—head and neck cancer	0.000698	0.00209	CcSEcCtD
Aripiprazole—Hot flush—Docetaxel—head and neck cancer	0.000698	0.00209	CcSEcCtD
Aripiprazole—Infestation—Fluorouracil—head and neck cancer	0.000697	0.00209	CcSEcCtD
Aripiprazole—Infestation NOS—Fluorouracil—head and neck cancer	0.000697	0.00209	CcSEcCtD
Aripiprazole—Menopausal symptoms—Docetaxel—head and neck cancer	0.000692	0.00207	CcSEcCtD
Aripiprazole—Visual disturbance—Docetaxel—head and neck cancer	0.000689	0.00206	CcSEcCtD
Aripiprazole—Atrial fibrillation—Docetaxel—head and neck cancer	0.000689	0.00206	CcSEcCtD
Aripiprazole—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000687	0.00206	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000684	0.00205	CcSEcCtD
Aripiprazole—Myocardial infarction—Fluorouracil—head and neck cancer	0.000684	0.00205	CcSEcCtD
Aripiprazole—Dermatitis bullous—Docetaxel—head and neck cancer	0.000683	0.00204	CcSEcCtD
Aripiprazole—Malaise—Hydroxyurea—head and neck cancer	0.000683	0.00204	CcSEcCtD
Aripiprazole—Stomatitis—Fluorouracil—head and neck cancer	0.00068	0.00203	CcSEcCtD
Aripiprazole—Conjunctivitis—Fluorouracil—head and neck cancer	0.000678	0.00203	CcSEcCtD
Aripiprazole—Urinary tract infection—Fluorouracil—head and neck cancer	0.000678	0.00203	CcSEcCtD
Aripiprazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000678	0.00203	CcSEcCtD
Aripiprazole—HRH1—trachea—head and neck cancer	0.000675	0.00393	CbGeAlD
Aripiprazole—HTR2A—connective tissue—head and neck cancer	0.000671	0.00391	CbGeAlD
Aripiprazole—Cardiac failure—Docetaxel—head and neck cancer	0.000669	0.002	CcSEcCtD
Aripiprazole—CHRM3—head—head and neck cancer	0.000667	0.00388	CbGeAlD
Aripiprazole—Lethargy—Docetaxel—head and neck cancer	0.000666	0.00199	CcSEcCtD
Aripiprazole—HTR1A—head—head and neck cancer	0.000664	0.00387	CbGeAlD
Aripiprazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000663	0.00199	CcSEcCtD
Aripiprazole—ADRA2A—trachea—head and neck cancer	0.000663	0.00386	CbGeAlD
Aripiprazole—Epistaxis—Fluorouracil—head and neck cancer	0.000658	0.00197	CcSEcCtD
Aripiprazole—Convulsion—Hydroxyurea—head and neck cancer	0.000656	0.00196	CcSEcCtD
Aripiprazole—Hyponatraemia—Docetaxel—head and neck cancer	0.000656	0.00196	CcSEcCtD
Aripiprazole—Sinusitis—Fluorouracil—head and neck cancer	0.000654	0.00196	CcSEcCtD
Aripiprazole—Pain in extremity—Docetaxel—head and neck cancer	0.000653	0.00195	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000653	0.00195	CcSEcCtD
Aripiprazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000651	0.00195	CcSEcCtD
Aripiprazole—Anorexia—Vinblastine—head and neck cancer	0.000646	0.00193	CcSEcCtD
Aripiprazole—Migraine—Docetaxel—head and neck cancer	0.000643	0.00192	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00064	0.00192	CcSEcCtD
Aripiprazole—HTR2A—epithelium—head and neck cancer	0.000637	0.00372	CbGeAlD
Aripiprazole—Discomfort—Hydroxyurea—head and neck cancer	0.000637	0.00191	CcSEcCtD
Aripiprazole—HTR7—head—head and neck cancer	0.000634	0.0037	CbGeAlD
Aripiprazole—Haemoglobin—Fluorouracil—head and neck cancer	0.000629	0.00188	CcSEcCtD
Aripiprazole—Rhinitis—Fluorouracil—head and neck cancer	0.000628	0.00188	CcSEcCtD
Aripiprazole—Haemorrhage—Fluorouracil—head and neck cancer	0.000626	0.00187	CcSEcCtD
Aripiprazole—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000623	0.00186	CcSEcCtD
Aripiprazole—Pharyngitis—Fluorouracil—head and neck cancer	0.000621	0.00186	CcSEcCtD
Aripiprazole—Oedema—Hydroxyurea—head and neck cancer	0.000618	0.00185	CcSEcCtD
Aripiprazole—Ataxia—Docetaxel—head and neck cancer	0.000614	0.00184	CcSEcCtD
Aripiprazole—Infection—Hydroxyurea—head and neck cancer	0.000614	0.00184	CcSEcCtD
Aripiprazole—ADRA1A—head—head and neck cancer	0.000612	0.00357	CbGeAlD
Aripiprazole—Paraesthesia—Vinblastine—head and neck cancer	0.000608	0.00182	CcSEcCtD
Aripiprazole—Dehydration—Docetaxel—head and neck cancer	0.000607	0.00182	CcSEcCtD
Aripiprazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000606	0.00181	CcSEcCtD
Aripiprazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000605	0.00181	CcSEcCtD
Aripiprazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.000603	0.0018	CcSEcCtD
Aripiprazole—Skin disorder—Hydroxyurea—head and neck cancer	0.0006	0.0018	CcSEcCtD
Aripiprazole—DRD2—head—head and neck cancer	0.0006	0.0035	CbGeAlD
Aripiprazole—Dry skin—Docetaxel—head and neck cancer	0.000599	0.00179	CcSEcCtD
Aripiprazole—Abdominal pain upper—Docetaxel—head and neck cancer	0.000597	0.00178	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000597	0.00178	CcSEcCtD
Aripiprazole—KCNH2—head—head and neck cancer	0.000591	0.00344	CbGeAlD
Aripiprazole—Breast disorder—Docetaxel—head and neck cancer	0.00059	0.00177	CcSEcCtD
Aripiprazole—Anorexia—Hydroxyurea—head and neck cancer	0.000589	0.00176	CcSEcCtD
Aripiprazole—Decreased appetite—Vinblastine—head and neck cancer	0.000589	0.00176	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000588	0.00176	CcSEcCtD
Aripiprazole—Cramp muscle—Docetaxel—head and neck cancer	0.000588	0.00176	CcSEcCtD
Aripiprazole—Nasopharyngitis—Docetaxel—head and neck cancer	0.000584	0.00175	CcSEcCtD
Aripiprazole—ADRA2C—head—head and neck cancer	0.000583	0.0034	CbGeAlD
Aripiprazole—Pain—Vinblastine—head and neck cancer	0.000579	0.00173	CcSEcCtD
Aripiprazole—Constipation—Vinblastine—head and neck cancer	0.000579	0.00173	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000576	0.00172	CcSEcCtD
Aripiprazole—Dysphagia—Docetaxel—head and neck cancer	0.000564	0.00169	CcSEcCtD
Aripiprazole—HTR2A—trachea—head and neck cancer	0.000564	0.00329	CbGeAlD
Aripiprazole—Feeling abnormal—Vinblastine—head and neck cancer	0.000558	0.00167	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000554	0.00166	CcSEcCtD
Aripiprazole—Alopecia—Fluorouracil—head and neck cancer	0.000553	0.00166	CcSEcCtD
Aripiprazole—Dyspnoea—Hydroxyurea—head and neck cancer	0.000551	0.00165	CcSEcCtD
Aripiprazole—Angina pectoris—Docetaxel—head and neck cancer	0.00055	0.00165	CcSEcCtD
Aripiprazole—Somnolence—Hydroxyurea—head and neck cancer	0.000549	0.00164	CcSEcCtD
Aripiprazole—Erythema—Fluorouracil—head and neck cancer	0.000545	0.00163	CcSEcCtD
Aripiprazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.000544	0.00163	CcSEcCtD
Aripiprazole—Decreased appetite—Hydroxyurea—head and neck cancer	0.000537	0.00161	CcSEcCtD
Aripiprazole—Abdominal pain—Vinblastine—head and neck cancer	0.000536	0.0016	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000533	0.0016	CcSEcCtD
Aripiprazole—Fatigue—Hydroxyurea—head and neck cancer	0.000533	0.00159	CcSEcCtD
Aripiprazole—Constipation—Hydroxyurea—head and neck cancer	0.000528	0.00158	CcSEcCtD
Aripiprazole—Pain—Hydroxyurea—head and neck cancer	0.000528	0.00158	CcSEcCtD
Aripiprazole—Neutropenia—Docetaxel—head and neck cancer	0.000528	0.00158	CcSEcCtD
Aripiprazole—ADRA2A—thyroid gland—head and neck cancer	0.000524	0.00306	CbGeAlD
Aripiprazole—HTR2B—lymph node—head and neck cancer	0.000519	0.00302	CbGeAlD
Aripiprazole—Weight increased—Docetaxel—head and neck cancer	0.000514	0.00154	CcSEcCtD
Aripiprazole—Vision blurred—Fluorouracil—head and neck cancer	0.000514	0.00154	CcSEcCtD
Aripiprazole—Weight decreased—Docetaxel—head and neck cancer	0.000511	0.00153	CcSEcCtD
Aripiprazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000509	0.00152	CcSEcCtD
Aripiprazole—Pneumonia—Docetaxel—head and neck cancer	0.000506	0.00151	CcSEcCtD
Aripiprazole—Anaemia—Fluorouracil—head and neck cancer	0.000504	0.00151	CcSEcCtD
Aripiprazole—Infestation—Docetaxel—head and neck cancer	0.000503	0.00151	CcSEcCtD
Aripiprazole—Infestation NOS—Docetaxel—head and neck cancer	0.000503	0.00151	CcSEcCtD
Aripiprazole—Hypersensitivity—Vinblastine—head and neck cancer	0.000499	0.00149	CcSEcCtD
Aripiprazole—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000496	0.00148	CcSEcCtD
Aripiprazole—Renal failure—Docetaxel—head and neck cancer	0.000495	0.00148	CcSEcCtD
Aripiprazole—Myocardial infarction—Docetaxel—head and neck cancer	0.000493	0.00148	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000493	0.00148	CcSEcCtD
Aripiprazole—Stomatitis—Docetaxel—head and neck cancer	0.000491	0.00147	CcSEcCtD
Aripiprazole—Jaundice—Docetaxel—head and neck cancer	0.000491	0.00147	CcSEcCtD
Aripiprazole—Conjunctivitis—Docetaxel—head and neck cancer	0.000489	0.00146	CcSEcCtD
Aripiprazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000488	0.00146	CcSEcCtD
Aripiprazole—Leukopenia—Fluorouracil—head and neck cancer	0.000488	0.00146	CcSEcCtD
Aripiprazole—Asthenia—Vinblastine—head and neck cancer	0.000486	0.00145	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000476	0.00142	CcSEcCtD
Aripiprazole—Epistaxis—Docetaxel—head and neck cancer	0.000475	0.00142	CcSEcCtD
Aripiprazole—HRH1—head—head and neck cancer	0.000474	0.00276	CbGeAlD
Aripiprazole—Convulsion—Fluorouracil—head and neck cancer	0.000472	0.00141	CcSEcCtD
Aripiprazole—Agranulocytosis—Docetaxel—head and neck cancer	0.00047	0.00141	CcSEcCtD
Aripiprazole—ADRA2A—head—head and neck cancer	0.000465	0.00271	CbGeAlD
Aripiprazole—Chest pain—Fluorouracil—head and neck cancer	0.000464	0.00139	CcSEcCtD
Aripiprazole—Myalgia—Fluorouracil—head and neck cancer	0.000464	0.00139	CcSEcCtD
Aripiprazole—Diarrhoea—Vinblastine—head and neck cancer	0.000464	0.00139	CcSEcCtD
Aripiprazole—Discomfort—Fluorouracil—head and neck cancer	0.000458	0.00137	CcSEcCtD
Aripiprazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000455	0.00136	CcSEcCtD
Aripiprazole—Haemoglobin—Docetaxel—head and neck cancer	0.000454	0.00136	CcSEcCtD
Aripiprazole—Rhinitis—Docetaxel—head and neck cancer	0.000453	0.00136	CcSEcCtD
Aripiprazole—Hepatitis—Docetaxel—head and neck cancer	0.000452	0.00135	CcSEcCtD
Aripiprazole—Haemorrhage—Docetaxel—head and neck cancer	0.000452	0.00135	CcSEcCtD
Aripiprazole—Hypoaesthesia—Docetaxel—head and neck cancer	0.00045	0.00135	CcSEcCtD
Aripiprazole—Confusional state—Fluorouracil—head and neck cancer	0.000448	0.00134	CcSEcCtD
Aripiprazole—Pharyngitis—Docetaxel—head and neck cancer	0.000448	0.00134	CcSEcCtD
Aripiprazole—Dizziness—Vinblastine—head and neck cancer	0.000448	0.00134	CcSEcCtD
Aripiprazole—Urinary tract disorder—Docetaxel—head and neck cancer	0.000446	0.00134	CcSEcCtD
Aripiprazole—Oedema peripheral—Docetaxel—head and neck cancer	0.000445	0.00133	CcSEcCtD
Aripiprazole—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000445	0.00133	CcSEcCtD
Aripiprazole—Oedema—Fluorouracil—head and neck cancer	0.000445	0.00133	CcSEcCtD
Aripiprazole—Connective tissue disorder—Docetaxel—head and neck cancer	0.000444	0.00133	CcSEcCtD
Aripiprazole—Asthenia—Hydroxyurea—head and neck cancer	0.000443	0.00133	CcSEcCtD
Aripiprazole—Urethral disorder—Docetaxel—head and neck cancer	0.000443	0.00133	CcSEcCtD
Aripiprazole—Infection—Fluorouracil—head and neck cancer	0.000442	0.00132	CcSEcCtD
Aripiprazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.000436	0.00131	CcSEcCtD
Aripiprazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000435	0.0013	CcSEcCtD
Aripiprazole—Visual impairment—Docetaxel—head and neck cancer	0.000435	0.0013	CcSEcCtD
Aripiprazole—Tachycardia—Fluorouracil—head and neck cancer	0.000434	0.0013	CcSEcCtD
Aripiprazole—Vomiting—Vinblastine—head and neck cancer	0.000431	0.00129	CcSEcCtD
Aripiprazole—Headache—Vinblastine—head and neck cancer	0.000424	0.00127	CcSEcCtD
Aripiprazole—Anorexia—Fluorouracil—head and neck cancer	0.000424	0.00127	CcSEcCtD
Aripiprazole—Diarrhoea—Hydroxyurea—head and neck cancer	0.000423	0.00127	CcSEcCtD
Aripiprazole—Eye disorder—Docetaxel—head and neck cancer	0.000422	0.00126	CcSEcCtD
Aripiprazole—Cardiac disorder—Docetaxel—head and neck cancer	0.000419	0.00125	CcSEcCtD
Aripiprazole—Flushing—Docetaxel—head and neck cancer	0.000419	0.00125	CcSEcCtD
Aripiprazole—ABCB1—epithelium—head and neck cancer	0.000418	0.00243	CbGeAlD
Aripiprazole—Hypotension—Fluorouracil—head and neck cancer	0.000416	0.00124	CcSEcCtD
Aripiprazole—KCNH2—lymph node—head and neck cancer	0.000414	0.00241	CbGeAlD
Aripiprazole—Angiopathy—Docetaxel—head and neck cancer	0.00041	0.00123	CcSEcCtD
Aripiprazole—Dizziness—Hydroxyurea—head and neck cancer	0.000409	0.00122	CcSEcCtD
Aripiprazole—ADRA2C—lymph node—head and neck cancer	0.000408	0.00238	CbGeAlD
Aripiprazole—Immune system disorder—Docetaxel—head and neck cancer	0.000408	0.00122	CcSEcCtD
Aripiprazole—Mediastinal disorder—Docetaxel—head and neck cancer	0.000407	0.00122	CcSEcCtD
Aripiprazole—Chills—Docetaxel—head and neck cancer	0.000405	0.00121	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000405	0.00121	CcSEcCtD
Aripiprazole—Nausea—Vinblastine—head and neck cancer	0.000402	0.0012	CcSEcCtD
Aripiprazole—Insomnia—Fluorouracil—head and neck cancer	0.000402	0.0012	CcSEcCtD
Aripiprazole—Paraesthesia—Fluorouracil—head and neck cancer	0.000399	0.0012	CcSEcCtD
Aripiprazole—Alopecia—Docetaxel—head and neck cancer	0.000399	0.00119	CcSEcCtD
Aripiprazole—Dyspnoea—Fluorouracil—head and neck cancer	0.000397	0.00119	CcSEcCtD
Aripiprazole—Mental disorder—Docetaxel—head and neck cancer	0.000396	0.00118	CcSEcCtD
Aripiprazole—HTR2A—head—head and neck cancer	0.000396	0.00231	CbGeAlD
Aripiprazole—Somnolence—Fluorouracil—head and neck cancer	0.000395	0.00118	CcSEcCtD
Aripiprazole—Erythema—Docetaxel—head and neck cancer	0.000393	0.00118	CcSEcCtD
Aripiprazole—Malnutrition—Docetaxel—head and neck cancer	0.000393	0.00118	CcSEcCtD
Aripiprazole—Vomiting—Hydroxyurea—head and neck cancer	0.000393	0.00118	CcSEcCtD
Aripiprazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000391	0.00117	CcSEcCtD
Aripiprazole—Rash—Hydroxyurea—head and neck cancer	0.00039	0.00117	CcSEcCtD
Aripiprazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000389	0.00116	CcSEcCtD
Aripiprazole—Headache—Hydroxyurea—head and neck cancer	0.000387	0.00116	CcSEcCtD
Aripiprazole—Decreased appetite—Fluorouracil—head and neck cancer	0.000387	0.00116	CcSEcCtD
Aripiprazole—Dysgeusia—Docetaxel—head and neck cancer	0.000385	0.00115	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000384	0.00115	CcSEcCtD
Aripiprazole—Back pain—Docetaxel—head and neck cancer	0.00038	0.00114	CcSEcCtD
Aripiprazole—Pain—Fluorouracil—head and neck cancer	0.00038	0.00114	CcSEcCtD
Aripiprazole—Muscle spasms—Docetaxel—head and neck cancer	0.000378	0.00113	CcSEcCtD
Aripiprazole—ABCB1—trachea—head and neck cancer	0.000369	0.00215	CbGeAlD
Aripiprazole—Nausea—Hydroxyurea—head and neck cancer	0.000367	0.0011	CcSEcCtD
Aripiprazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.000367	0.0011	CcSEcCtD
Aripiprazole—Anaemia—Docetaxel—head and neck cancer	0.000364	0.00109	CcSEcCtD
Aripiprazole—CYP2D6—head—head and neck cancer	0.00036	0.0021	CbGeAlD
Aripiprazole—Urticaria—Fluorouracil—head and neck cancer	0.000353	0.00106	CcSEcCtD
Aripiprazole—Syncope—Docetaxel—head and neck cancer	0.000353	0.00106	CcSEcCtD
Aripiprazole—Leukopenia—Docetaxel—head and neck cancer	0.000352	0.00105	CcSEcCtD
Aripiprazole—Body temperature increased—Fluorouracil—head and neck cancer	0.000352	0.00105	CcSEcCtD
Aripiprazole—Palpitations—Docetaxel—head and neck cancer	0.000348	0.00104	CcSEcCtD
Aripiprazole—Loss of consciousness—Docetaxel—head and neck cancer	0.000346	0.00103	CcSEcCtD
Aripiprazole—Cough—Docetaxel—head and neck cancer	0.000343	0.00103	CcSEcCtD
Aripiprazole—Convulsion—Docetaxel—head and neck cancer	0.000341	0.00102	CcSEcCtD
Aripiprazole—Hypertension—Docetaxel—head and neck cancer	0.00034	0.00102	CcSEcCtD
Aripiprazole—Myalgia—Docetaxel—head and neck cancer	0.000335	0.001	CcSEcCtD
Aripiprazole—Arthralgia—Docetaxel—head and neck cancer	0.000335	0.001	CcSEcCtD
Aripiprazole—Chest pain—Docetaxel—head and neck cancer	0.000335	0.001	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000333	0.000995	CcSEcCtD
Aripiprazole—HRH1—lymph node—head and neck cancer	0.000332	0.00193	CbGeAlD
Aripiprazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.000328	0.00098	CcSEcCtD
Aripiprazole—Dry mouth—Docetaxel—head and neck cancer	0.000327	0.00098	CcSEcCtD
Aripiprazole—ADRA2A—lymph node—head and neck cancer	0.000326	0.0019	CbGeAlD
Aripiprazole—Confusional state—Docetaxel—head and neck cancer	0.000324	0.000969	CcSEcCtD
Aripiprazole—ABCB1—lymphoid tissue—head and neck cancer	0.000322	0.00188	CbGeAlD
Aripiprazole—Anaphylactic shock—Docetaxel—head and neck cancer	0.000321	0.000961	CcSEcCtD
Aripiprazole—Oedema—Docetaxel—head and neck cancer	0.000321	0.000961	CcSEcCtD
Aripiprazole—Infection—Docetaxel—head and neck cancer	0.000319	0.000954	CcSEcCtD
Aripiprazole—Shock—Docetaxel—head and neck cancer	0.000316	0.000945	CcSEcCtD
Aripiprazole—Nervous system disorder—Docetaxel—head and neck cancer	0.000315	0.000942	CcSEcCtD
Aripiprazole—Pruritus—Fluorouracil—head and neck cancer	0.000315	0.000942	CcSEcCtD
Aripiprazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.000314	0.00094	CcSEcCtD
Aripiprazole—Tachycardia—Docetaxel—head and neck cancer	0.000313	0.000937	CcSEcCtD
Aripiprazole—Skin disorder—Docetaxel—head and neck cancer	0.000312	0.000933	CcSEcCtD
Aripiprazole—Anorexia—Docetaxel—head and neck cancer	0.000306	0.000916	CcSEcCtD
Aripiprazole—Diarrhoea—Fluorouracil—head and neck cancer	0.000304	0.000911	CcSEcCtD
Aripiprazole—Hypotension—Docetaxel—head and neck cancer	0.0003	0.000898	CcSEcCtD
Aripiprazole—Dizziness—Fluorouracil—head and neck cancer	0.000294	0.00088	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000292	0.000875	CcSEcCtD
Aripiprazole—ABCB1—thyroid gland—head and neck cancer	0.000292	0.0017	CbGeAlD
Aripiprazole—Insomnia—Docetaxel—head and neck cancer	0.00029	0.000869	CcSEcCtD
Aripiprazole—Paraesthesia—Docetaxel—head and neck cancer	0.000288	0.000863	CcSEcCtD
Aripiprazole—Dyspnoea—Docetaxel—head and neck cancer	0.000286	0.000856	CcSEcCtD
Aripiprazole—Somnolence—Docetaxel—head and neck cancer	0.000285	0.000854	CcSEcCtD
Aripiprazole—Vomiting—Fluorouracil—head and neck cancer	0.000283	0.000846	CcSEcCtD
Aripiprazole—Dyspepsia—Docetaxel—head and neck cancer	0.000283	0.000846	CcSEcCtD
Aripiprazole—Rash—Fluorouracil—head and neck cancer	0.00028	0.000839	CcSEcCtD
Aripiprazole—Dermatitis—Fluorouracil—head and neck cancer	0.00028	0.000838	CcSEcCtD
Aripiprazole—Decreased appetite—Docetaxel—head and neck cancer	0.000279	0.000835	CcSEcCtD
Aripiprazole—Headache—Fluorouracil—head and neck cancer	0.000279	0.000834	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000277	0.000829	CcSEcCtD
Aripiprazole—Fatigue—Docetaxel—head and neck cancer	0.000277	0.000828	CcSEcCtD
Aripiprazole—Pain—Docetaxel—head and neck cancer	0.000275	0.000821	CcSEcCtD
Aripiprazole—Constipation—Docetaxel—head and neck cancer	0.000275	0.000821	CcSEcCtD
Aripiprazole—Feeling abnormal—Docetaxel—head and neck cancer	0.000265	0.000792	CcSEcCtD
Aripiprazole—Nausea—Fluorouracil—head and neck cancer	0.000264	0.00079	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000262	0.000785	CcSEcCtD
Aripiprazole—ABCB1—head—head and neck cancer	0.000259	0.00151	CbGeAlD
Aripiprazole—Body temperature increased—Docetaxel—head and neck cancer	0.000254	0.000759	CcSEcCtD
Aripiprazole—Abdominal pain—Docetaxel—head and neck cancer	0.000254	0.000759	CcSEcCtD
Aripiprazole—Hypersensitivity—Docetaxel—head and neck cancer	0.000237	0.000708	CcSEcCtD
Aripiprazole—Asthenia—Docetaxel—head and neck cancer	0.00023	0.000689	CcSEcCtD
Aripiprazole—Pruritus—Docetaxel—head and neck cancer	0.000227	0.00068	CcSEcCtD
Aripiprazole—Diarrhoea—Docetaxel—head and neck cancer	0.00022	0.000657	CcSEcCtD
Aripiprazole—Dizziness—Docetaxel—head and neck cancer	0.000212	0.000635	CcSEcCtD
Aripiprazole—Vomiting—Docetaxel—head and neck cancer	0.000204	0.000611	CcSEcCtD
Aripiprazole—Rash—Docetaxel—head and neck cancer	0.000202	0.000606	CcSEcCtD
Aripiprazole—Dermatitis—Docetaxel—head and neck cancer	0.000202	0.000605	CcSEcCtD
Aripiprazole—Headache—Docetaxel—head and neck cancer	0.000201	0.000602	CcSEcCtD
Aripiprazole—Nausea—Docetaxel—head and neck cancer	0.000191	0.000571	CcSEcCtD
Aripiprazole—ABCB1—lymph node—head and neck cancer	0.000182	0.00106	CbGeAlD
Aripiprazole—ADRA2C—Signaling Pathways—PTEN—head and neck cancer	1.27e-05	9.66e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.26e-05	9.53e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	1.25e-05	9.51e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—HRAS—head and neck cancer	1.25e-05	9.51e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	1.25e-05	9.51e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—PIK3CA—head and neck cancer	1.25e-05	9.5e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	1.25e-05	9.48e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	1.25e-05	9.45e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—PIK3CA—head and neck cancer	1.24e-05	9.44e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK1—head and neck cancer	1.24e-05	9.44e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—head and neck cancer	1.24e-05	9.44e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	1.24e-05	9.43e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—head and neck cancer	1.24e-05	9.42e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.24e-05	9.42e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTEN—head and neck cancer	1.24e-05	9.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.24e-05	9.37e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	1.23e-05	9.36e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—head and neck cancer	1.23e-05	9.34e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—head and neck cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	1.23e-05	9.33e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—head and neck cancer	1.23e-05	9.32e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK1—head and neck cancer	1.23e-05	9.31e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—head and neck cancer	1.23e-05	9.31e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	1.22e-05	9.27e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.22e-05	9.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—head and neck cancer	1.22e-05	9.25e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	1.22e-05	9.25e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—PIK3CA—head and neck cancer	1.22e-05	9.25e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	1.22e-05	9.22e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—head and neck cancer	1.21e-05	9.2e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—head and neck cancer	1.21e-05	9.19e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	1.21e-05	9.19e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.21e-05	9.17e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—head and neck cancer	1.21e-05	9.15e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—head and neck cancer	1.2e-05	9.13e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—head and neck cancer	1.2e-05	9.12e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—PIK3CA—head and neck cancer	1.2e-05	9.1e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	1.2e-05	9.1e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—head and neck cancer	1.2e-05	9.09e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.2e-05	9.08e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	1.2e-05	9.07e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	1.19e-05	9.02e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—head and neck cancer	1.19e-05	9e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—head and neck cancer	1.18e-05	8.98e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PIK3CA—head and neck cancer	1.18e-05	8.98e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.18e-05	8.97e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—head and neck cancer	1.18e-05	8.94e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.18e-05	8.94e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—head and neck cancer	1.18e-05	8.93e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	1.18e-05	8.92e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCND1—head and neck cancer	1.18e-05	8.92e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCND1—head and neck cancer	1.17e-05	8.89e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.17e-05	8.88e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCND1—head and neck cancer	1.17e-05	8.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK3—head and neck cancer	1.17e-05	8.84e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—HRAS—head and neck cancer	1.16e-05	8.8e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—head and neck cancer	1.16e-05	8.8e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—HRAS—head and neck cancer	1.16e-05	8.79e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCND1—head and neck cancer	1.16e-05	8.77e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.16e-05	8.77e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	1.15e-05	8.75e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—HRAS—head and neck cancer	1.15e-05	8.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—head and neck cancer	1.15e-05	8.73e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.15e-05	8.68e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—head and neck cancer	1.14e-05	8.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	1.14e-05	8.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—head and neck cancer	1.14e-05	8.64e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.14e-05	8.62e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PTEN—head and neck cancer	1.13e-05	8.61e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTEN—head and neck cancer	1.13e-05	8.6e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PIK3CA—head and neck cancer	1.13e-05	8.59e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	1.13e-05	8.59e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PTEN—head and neck cancer	1.13e-05	8.58e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—HRAS—head and neck cancer	1.13e-05	8.55e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.13e-05	8.55e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PTEN—head and neck cancer	1.13e-05	8.55e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	1.12e-05	8.53e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	1.12e-05	8.5e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.12e-05	8.49e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	1.12e-05	8.49e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—head and neck cancer	1.12e-05	8.48e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PTEN—head and neck cancer	1.12e-05	8.47e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	1.11e-05	8.43e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HRAS—head and neck cancer	1.11e-05	8.42e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.11e-05	8.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK1—head and neck cancer	1.11e-05	8.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—head and neck cancer	1.11e-05	8.41e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.11e-05	8.4e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—head and neck cancer	1.11e-05	8.4e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.11e-05	8.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	1.1e-05	8.37e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	1.1e-05	8.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—head and neck cancer	1.1e-05	8.34e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—head and neck cancer	1.1e-05	8.31e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HRAS—head and neck cancer	1.09e-05	8.3e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	1.09e-05	8.26e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK3—head and neck cancer	1.09e-05	8.25e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	1.09e-05	8.24e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—TYMS—head and neck cancer	1.08e-05	8.23e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—head and neck cancer	1.08e-05	8.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—head and neck cancer	1.07e-05	8.15e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.07e-05	8.13e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	1.07e-05	8.13e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	1.07e-05	8.12e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	1.07e-05	8.12e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—head and neck cancer	1.07e-05	8.11e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—head and neck cancer	1.07e-05	8.08e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.06e-05	8.07e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.06e-05	8.07e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HRAS—head and neck cancer	1.06e-05	8.03e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HRAS—head and neck cancer	1.05e-05	7.95e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—head and neck cancer	1.04e-05	7.92e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.04e-05	7.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK1—head and neck cancer	1.04e-05	7.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—head and neck cancer	1.04e-05	7.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	1.03e-05	7.85e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.03e-05	7.84e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—head and neck cancer	1.03e-05	7.82e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.03e-05	7.79e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—head and neck cancer	1.03e-05	7.79e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—head and neck cancer	1.02e-05	7.77e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—head and neck cancer	1.02e-05	7.77e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—head and neck cancer	1.02e-05	7.76e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	1.02e-05	7.75e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	1.02e-05	7.73e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	1.02e-05	7.73e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	1.02e-05	7.72e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—head and neck cancer	1.02e-05	7.71e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.02e-05	7.71e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.02e-05	7.71e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—head and neck cancer	1.01e-05	7.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—head and neck cancer	1.01e-05	7.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—head and neck cancer	1.01e-05	7.65e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	1.01e-05	7.63e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HRAS—head and neck cancer	9.99e-06	7.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—head and neck cancer	9.99e-06	7.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	9.96e-06	7.55e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—head and neck cancer	9.96e-06	7.55e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK3—head and neck cancer	9.88e-06	7.49e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HRAS—head and neck cancer	9.86e-06	7.48e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—head and neck cancer	9.81e-06	7.44e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—head and neck cancer	9.8e-06	7.43e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	9.72e-06	7.37e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	9.71e-06	7.36e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK3—head and neck cancer	9.7e-06	7.35e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—head and neck cancer	9.67e-06	7.33e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	9.66e-06	7.33e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	9.63e-06	7.31e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—head and neck cancer	9.62e-06	7.3e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	9.54e-06	7.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	9.51e-06	7.22e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—head and neck cancer	9.51e-06	7.21e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK1—head and neck cancer	9.4e-06	7.13e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—head and neck cancer	9.39e-06	7.12e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—head and neck cancer	9.39e-06	7.12e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—head and neck cancer	9.35e-06	7.09e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	9.34e-06	7.09e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—head and neck cancer	9.31e-06	7.06e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	9.29e-06	7.04e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—head and neck cancer	9.26e-06	7.02e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	9.25e-06	7.02e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	9.25e-06	7.01e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—head and neck cancer	9.25e-06	7.01e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—head and neck cancer	9.24e-06	7.01e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	9.24e-06	7.01e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK1—head and neck cancer	9.23e-06	7e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—head and neck cancer	9.22e-06	7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	9.2e-06	6.97e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—head and neck cancer	9.19e-06	6.97e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	9.17e-06	6.95e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—head and neck cancer	9.16e-06	6.95e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	9.08e-06	6.88e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—head and neck cancer	9.08e-06	6.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	9.05e-06	6.87e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	9.05e-06	6.86e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—head and neck cancer	9.04e-06	6.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—head and neck cancer	8.99e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—head and neck cancer	8.98e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HRAS—head and neck cancer	8.98e-06	6.81e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—head and neck cancer	8.94e-06	6.78e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HRAS—head and neck cancer	8.9e-06	6.75e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	8.84e-06	6.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	8.84e-06	6.7e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—head and neck cancer	8.82e-06	6.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—head and neck cancer	8.78e-06	6.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—head and neck cancer	8.73e-06	6.62e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—head and neck cancer	8.7e-06	6.6e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—head and neck cancer	8.69e-06	6.59e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HRAS—head and neck cancer	8.59e-06	6.52e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTEN—head and neck cancer	8.56e-06	6.49e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—head and neck cancer	8.56e-06	6.49e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HRAS—head and neck cancer	8.55e-06	6.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	8.41e-06	6.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	8.41e-06	6.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HRAS—head and neck cancer	8.31e-06	6.3e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	8.18e-06	6.21e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	8.15e-06	6.18e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTEN—head and neck cancer	8.06e-06	6.11e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	8.02e-06	6.08e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	8.01e-06	6.07e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—head and neck cancer	8e-06	6.07e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	7.98e-06	6.05e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	7.95e-06	6.03e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—head and neck cancer	7.93e-06	6.01e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—head and neck cancer	7.89e-06	5.98e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	7.88e-06	5.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—head and neck cancer	7.86e-06	5.96e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	7.86e-06	5.96e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—head and neck cancer	7.77e-06	5.89e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—head and neck cancer	7.76e-06	5.89e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—head and neck cancer	7.74e-06	5.87e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—head and neck cancer	7.72e-06	5.85e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—head and neck cancer	7.7e-06	5.84e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—head and neck cancer	7.62e-06	5.78e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—head and neck cancer	7.6e-06	5.76e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—head and neck cancer	7.59e-06	5.75e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—head and neck cancer	7.55e-06	5.72e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HRAS—head and neck cancer	7.54e-06	5.72e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—HRAS—head and neck cancer	7.42e-06	5.63e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HRAS—head and neck cancer	7.41e-06	5.62e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HRAS—head and neck cancer	7.38e-06	5.6e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HRAS—head and neck cancer	7.36e-06	5.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—head and neck cancer	7.34e-06	5.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	7.3e-06	5.54e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HRAS—head and neck cancer	7.29e-06	5.53e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	7.27e-06	5.51e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	7.22e-06	5.48e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—head and neck cancer	7.13e-06	5.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—head and neck cancer	7.06e-06	5.35e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	6.75e-06	5.12e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—head and neck cancer	6.66e-06	5.05e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—head and neck cancer	6.55e-06	4.97e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—head and neck cancer	6.54e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—head and neck cancer	6.53e-06	4.96e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—head and neck cancer	6.52e-06	4.94e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—head and neck cancer	6.5e-06	4.93e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—head and neck cancer	6.43e-06	4.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	6.42e-06	4.87e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	6.04e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—head and neck cancer	6.04e-06	4.58e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	5.96e-06	4.52e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.69e-06	4.31e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTEN—head and neck cancer	5.27e-06	4e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—head and neck cancer	4.93e-06	3.74e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—head and neck cancer	4.65e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.72e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—head and neck cancer	3.04e-06	2.3e-05	CbGpPWpGaD
